News & Articles

In this on-demand webinar, discover how to rapidly diagnose antimicrobial resistance for appropriate therapy

The extraction-free saliva-based test detects nucleic acid from the SARS-CoV-2 virus

The acquisition aims to meet continuing demand for COVID-related testing as well as develop point-of care tests for future infectious diseases

QIAstat-Dx and NeuMoDx tests continue to detect all known viral variants extremely effectively

Learn about why patients are admitted to an ICU, the physiological support, monitoring, and treatments available and the impact COVID-19 globally

Watch this on-demand accredited webinar to learn about the role serology plays in the clinician toolbox for managing COVID-19

Explore topics such as UV-Vis spectroscopy, DNA and RNA quantification, pediatric diagnostics and COVID-19 serology testing

The integrated solution offers deeper insight into therapy resistance and relapse, saving billions in drug development costs

Watch this on-demand webinar to learn about the potential of computer-assisted interpretation and linking disease markers identified by NMR to the metagene database

Gold-standard testing of individuals without COVID-19 symptoms key to controlling the spread

Explore topics from single-cell RNA sequencing sample preparation and precise weighing processes to COVID-19 serology testing and pediatric diagnostics

Dr. Komal Kumar Javarappa shares insights from the multidisciplinary forefront of immuno-oncology, where translational biologists race against time to optimize new cancer therapies

Watch this on-demand webinar to learn more about manipulating the genes within physiologically relevant human immune cells

Join us on Friday, January 22, to discover why serology testing is necessary to understand whether vaccination results in seroconversion

Working with the UK government, first vaccinations are to begin early in the new year

The real-time RT-PCR assay can simultaneously detect and differentiate 8 target genes, the first and only test to do so in the world

Preliminary results show 92% sensitivity and 100% specificity, compared with RT-PCR

The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable